Prenetics Global Limited Class A Ordinary Share (PRE)

About PRE

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headq…

Sector

Finance

Industry

Blank Checks

Employees

98

Website

ir.prenetics.com/

Fundamentals

1-day range

$25.07$26.29

Market cap

$317.50M

P/E (trailing)

—

P/E (forward)

-9.63

EPS (trailing)

$-3.30

Dividend yield

—

Beta

0.32

Avg. volume

237.8K

Forecasts

5 analyst ratings

Prenetics Global Limited Class A Ordinary Share Competitors

Chosen by industry and closest market cap.

• PRE

  Prenetics Global Limited Class A Ordinary Share

  $25.85

  ▼ 1.52%
  Market cap $317.50MP/E —
  $7.27$26.5
• BZAI

  Blaize Holdings Inc. Common Stock

  $0.53

  ▲ 3.52%
  Market cap $120.52MP/E —
  $0.42$6.76
• MLEC

  Moolec Science SA Ordinary Shares

  $6.8

  ▼ 0.15%
  Market cap $4.95MP/E —
  $3.07$23.22
• ASPCU

  A SPAC III Acquisition Corp. Unit

  $11.99

  ▲ 0.00%
  Market cap $—P/E 30.34
  $10.3$63.98
• BCAR

  D. Boral ARC Acquisition I Corp. Class A Ordinary Shares

  $4.69

  ▼ 19.14%
  Market cap $—P/E 37.98
  $3.99$11.17
• BSAA

  BEST SPAC I Acquisition Corp. Class A Ordinary Shares

  $10.9

  ▼ 3.02%
  Market cap $—P/E 22.30
  $10$17.2
• ATIIU

  Archimedes Tech SPAC Partners II Co. Unit

  $11.3

  ▼ 0.79%
  Market cap $—P/E 36.97
  $10.19$11.4

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• B. Riley Securities Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $37
  benzinga · 8/27/2026
• B. Riley Securities Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $37
  Benzinga · 8/27/2026
• Prenetics Global CEO Danny Yeung And CFO Brian Rosin Acquire Total Of $1M Worth Of Shares In Open Market Purchases
  Benzinga · 8/26/2026
• Prenetics Global: Marketing Mastery The Key To Robust Revenue Growth
  SeekingAlpha · 8/24/2026
• Prenetics Global Limited (PRE) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/22/2026
• Prenetics Global Sees FY2026 Sales $220.000M-$230.000M vs $214.071M Est
  Benzinga · 8/18/2026
• Prenetics Global Sees Q3 Sales $63.000M-$64.000M vs $59.310M Est
  Benzinga · 8/18/2026
• Prenetics Global Initiates FY2027 guidance of $400 million+ in IM8 revenue
  Benzinga · 8/18/2026
• Prenetics Global Q2 EPS $(0.53) Beats $(0.71) Estimate, Sales $46.488M Miss $48.920M Estimate
  Benzinga · 8/18/2026

• Rosin Brian J · August 25, 2026 · Buy

  5.1K @ $22.8
• Rosin Brian J · August 24, 2026 · Buy

  18.0K @ $21.19
• Yeung Danny Sheng Wu · August 24, 2026 · Buy

  11.2K @ $21.4
• Yeung Danny Sheng Wu · August 24, 2026 · Buy

  6.0K @ $20.9
• Lo Hoi Chun · August 21, 2026 · Option Exercise

  491.0K @ $0.0001
• Lo Hoi Chun · August 21, 2026 · Option Exercise

  45.8K
• Lo Hoi Chun · August 21, 2026 · Option Exercise

  32.7K @ $0.0001
• Yeung Danny Sheng Wu · August 20, 2026 · Option Exercise

  809.3K @ $0.0001
• Yeung Danny Sheng Wu · August 20, 2026 · Buy

  7.5K @ $18.31
• Yeung Danny Sheng Wu · August 20, 2026 · J

  49.9K
• Yeung Danny Sheng Wu · August 20, 2026 · Option Exercise

  54.0K @ $0.0001
• Hudson Blake Leogrande · August 4, 2026 · Option Exercise

  2.0K
• Hudson Blake Leogrande · July 4, 2026 · Option Exercise

  2.0K
• Yin Pan Cheng · June 15, 2026 · Option Exercise

  15.9K
• David Vanderveen · June 15, 2026 · Option Exercise

  8.7K